Lupin Atlantis Holdings SA

Lupin Atlantis Holdings SA is a key international subsidiary of Lupin Limited, a leading global pharmaceutical company. Based in Switzerland, this entity manages the group's international business operations, intellectual property, and strategic licensing agreements. Lupin specializes in a broad range of products, including complex generics, biosimilars, and specialty medicines, with a particular focus on respiratory, cardiovascular, and oncology therapeutic areas. The company is a major player in the global generics market, maintaining a significant presence in the United States, Europe, and India. Lupin Atlantis Holdings SA often serves as the primary vehicle for global partnerships and the commercialization of the company's innovative pipeline.